RPLP0P2 rs145265196: Longevity Research and Genetics
The variant rs145265196 is a rare single-nucleotide polymorphism located on chromosome 11 in the genomic neighborhood of the RPLP0P2 locus. In genome-wide association studies evaluating exceptional human lifespan, this regulatory variant has been highlighted with suggestive statistical significance. However, current biological and clinical evidence remains limited, meaning it serves as an intriguing research lead rather than an established predictor of lifespan.
What each genotype means
| Genotype | What the research suggests | Reading |
|---|---|---|
| Major Allele Homozygote (Reference) | This genotype represents the standard baseline sequence found in more than 99% of global populations. Individuals with this genotype carry two copies of the common ancestral allele at this chromosome 11 locus. It is not associated with any altered statistical shift in longevity studies and reflects typical population genetics. | Informational |
| Heterozygote (Minor Allele Carrier) | This genotype indicates the presence of one rare minor allele and one common reference allele at rs145265196. In preliminary genomic scans, this minor allele showed a suggestive statistical association with cohorts exhibiting extreme human longevity. Given the limited scientific evidence, carrying this rare allele is not a deterministic guarantee of a longer lifespan. | Favorable |
| Minor Allele Homozygote (Rare) | This genotype represents individuals carrying two copies of the rare minor allele at this regulatory locus. Due to the very low population frequency of roughly 0.003, this combination is exceptionally scarce in global reference datasets. Reliable phenotypic conclusions cannot be drawn for this group because observed sample sizes in published cohorts remain extremely small. | Informational |
Genomic Location and Variant Characteristics
The single-nucleotide variant rs145265196 is situated on chromosome 11 within non-coding regulatory DNA near RPLP0P2. Because it resides outside canonical protein-coding sequences, researchers classify it as a non-coding regulatory variant that may influence nearby transcriptional activity or chromatin conformation. Reference genetic databases, such as NCBI dbSNP and the Ensembl Genome Browser, track rs145265196 across modern human assemblies. Unlike coding missense variants that directly alter amino acid sequences, non-coding variants typically exert subtle, tissue-dependent regulatory effects on neighboring elements. Because of its location in an intergenic or flank region, investigating how this specific nucleotide substitution affects transcriptional machinery remains an active area of study in human functional genomics.
The Biological Context of RPLP0P2
The nearest mapped gene locus to rs145265196 is RPLP0P2, officially designated as Ribosomal Protein Lateral Stalk Subunit P0 Pseudogene 2. While historically annotated as a processed pseudogene derived from the core ribosomal gene RPLP0, modern transcriptomic investigations reveal that certain pseudogenes are transcribed into functional long non-coding RNAs (lncRNAs). Research cataloged in NCBI Gene and biomedical publications suggests that transcribed lncRNA from RPLP0P2 can participate in cellular regulatory networks, including cell proliferation, apoptosis, and cellular stress responses. In cellular biology models, altered expression of RPLP0P2 has been observed across various human tissue types, illustrating that non-coding and pseudogene loci can play regulatory roles in physiological aging and homeostasis.
Longevity Associations and Research Evidence
The primary interest in rs145265196 stems from genome-wide association studies (GWAS) and gene-based scans investigating exceptional human longevity and healthspan. Longevity is a highly complex, polygenic trait shaped by thousands of variants, environmental factors, and lifestyle choices. In exploratory genetic analyses of long-lived cohorts, rs145265196 reached suggestive genome-wide significance, indicating a possible statistical correlation with extended survival. However, scientific evidence supporting this association is currently categorized as limited. Suggestive statistical signals require large-scale replication in independent cohorts across diverse global ancestries before researchers can establish a definitive, reproducible link to extended lifespan.
Frequency and Distribution Across Global Populations
According to broad population datasets, including the Genome Aggregation Database (gnomAD) and the 1000 Genomes Project, rs145265196 is a rare human genetic variant. It presents with an estimated minor allele frequency of approximately 0.003 (0.3%) across aggregate global reference populations. Because it is uncommon, the vast majority of individuals carry two copies of the major reference allele, while only a small fraction of people possess a single copy of the minor allele. Homozygous carriers of the minor allele are extraordinarily rare. Because rare variants are subject to strong genetic drift and historical founder effects, population frequencies can vary widely across specific continental and regional ancestries.
Understanding What This Information Means for You
Discovering your genotype at rs145265196 provides a window into fundamental genetic research, but it does not dictate your individual health outcome or lifespan. Because this variant carries limited evidence of association and operates within a vast, polygenic background, having or lacking the minor allele cannot guarantee longevity or predict age of death. Genetic tests reporting this marker should not be used as clinical diagnostic tools, nor should they guide independent medical decisions. Instead, foundational lifestyle choices—including balanced nutrition, regular physical activity, stress management, adequate sleep, and routine clinical screenings—remain the established determinants of healthy aging and personal healthspan.
How common is this variant?
The variant rs145265196 is a rare single-nucleotide polymorphism with a minor allele frequency of approximately 0.003 (0.3%) across global reference populations. The vast majority of individuals worldwide are homozygous for the common reference allele.
Frequently asked questions
Does having the rs145265196 variant mean I will live to 100?
No, having the rare allele at rs145265196 does not guarantee exceptional longevity. Longevity is influenced by thousands of genetic markers alongside daily lifestyle habits, healthcare access, and environmental factors. The evidence linking this variant to extended lifespan remains preliminary and suggestive.
What is the function of the RPLP0P2 gene?
RPLP0P2 is historically classified as a ribosomal pseudogene, a duplicate sequence derived from the RPLP0 gene. Emerging molecular studies indicate that it may produce non-coding RNA that interacts with cellular regulatory pathways, although its exact physiological mechanisms are still being explored.
How common is rs145265196 in the general population?
It is quite rare, occurring with an estimated minor allele frequency of about 0.003 (roughly 1 in every 300 alleles) across diverse human populations. Consequently, fewer than 1% of people carry even a single copy of this variant.
Can I use my rs145265196 result to make medical decisions?
No, this genetic marker has no approved clinical utility or diagnostic power. You should never alter medical treatments, medications, or health regimens based on this research variant, and any health-related questions should be reviewed directly with a licensed healthcare professional.
Sources & further reading
Educational information only, last refreshed 9/9/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs145265196?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29